Evidence map›Paper›PMID 38450743›Full record

Trial reportSocial cognitive and affective neuroscience2024

The pill you don't have to take that is still effective: neural correlates of imaginary placebo intake for regulating disgust.

Anne Schienle, Wolfgang Kogler, Arved Seibel, Albert Wabnegger

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Social cognitive and affective neuroscience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Anne SchienleDepartment of Clinical Psychology, University of Graz, Universitaetsplatz 2, Graz 8010, Austria.ORCID 0000-0003-2173-6626
Wolfgang KoglerDepartment of Clinical Psychology, University of Graz, Universitaetsplatz 2, Graz 8010, Austria.
Arved SeibelDepartment of Clinical Psychology, University of Graz, Universitaetsplatz 2, Graz 8010, Austria.
Albert WabneggerDepartment of Clinical Psychology, University of Graz, Universitaetsplatz 2, Graz 8010, Austria.
University of Graz · AT

Funding

Fundação Bial 2022
6 · The paper itself

Abstract

A commonly established protocol for the administration of open-label placebos (OLPs)-placebos honestly prescribed-emphasizes the necessity of ingesting the pill for the placebo effect to manifest. The current functional magnetic resonance imaging study used a novel approach to OLP administration: the imaginary intake of an OLP pill for regulating disgust. A total of 99 females were randomly allocated to one of three groups that either swallowed a placebo pill (OLP Pill), imagined the intake of a placebo pill (Imaginary Pill) or passively viewed (PV) repulsive and neutral images. The imaginary pill reduced reported disgust more effectively than the OLP pill and was also perceived as a more plausible method to reduce emotional distress. Relative to the OLP pill, the imaginary pill lowered neural activity in a region of interest involved in disgust processing: the pallidum. No significant differences in brain activation were found when comparing the OLP pill with PV. These findings highlight that imagining the intake of an OLP emerged as a superior method for regulating feelings of disgust compared to the actual ingestion of a placebo pill. The study's innovative approach sheds new light on the potential of placebo interventions in emotion regulation.

Indexed as

DisgustBrainEmotionsFemaleHumansPlacebo EffectdisgustfMRIimageryopen-label placeboplausibility

Identifiers

PMID38450743
PMCPMC11227952
OpenAlexW4392553361

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.